Page Comparison

Quorum evalution (two-thirds (2/3) of the Voting Representatives shall be necessary to constitute a quorum for the transaction of business)

Currently we have 18 named members, so 2/3 = 12 (excluding chair and government members)

Open Meeting

Feedback from FDA , specifically Collaborative Community leadership in CDRH on our Charter

1. They recommended that the percentages of various groups be more “fungible”… In that what happens if you are not able get the exact percent representation from particular groups? So anticipate that somehow by saying that is a goal, and that leadership can approve deviations from those numbers, or have the documents say that they are guidelines, not absolute.

2. For the SHIELD projects, they want to see some goals that are long-term sustaining projects. Not projects that look like they will wrap up in 1-2 years… The question being is this a temporary type group that we might support in the short term more as an focus group, or is this a longer term group that is worth FDA planning to be in partnership with for a long time.

Feedback from ONC on Roadmap (FINAL VERSION)

Was discussed on May 30th call - any follow up?

Review Working Group Committee list and establish SC representation

Working Groups

Created Confluence pages for the 4 priority groups - announcements on May 30th call

Leads will find call time and invite interested people

NPRM feedback

Call schedule in the summer

June 13th - Andrea will lead - topics:

• final comments on NRPM and maybe vote / or do by email

June 20 - Andrea will lead

June 27 - ALL SHIELD call

July 4 - need to reschedule - move to July 11th or just cancel?

Meetings

https://loinc.org/conference/atlanta-2023/ October 17-20

Submit proposals by May 31

Should SHIELD submit something?

Next call

June 20. 2023 12 -1 PM EDT

Adjourned